Deerfield Partners LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Deerfield Partners LP
CIK #0001301041
EDGAR Form CIK 2011 - 2026
3 [0001301041]
4 [0001301041]
D [0001301041]
Form 3/4/5 Subject 2011 - 2026
Deerfield Mgmt HIF LP
Deerfield Private Design Fund IV LP
Deerfield Management Company LP
Deerfield Mgmt III LP
Deerfield Capital LP
Flynn James E
Zafgen Inc
Deerfield Private Design Fund III LP
Deerfield Partners LP
Deerfield Healthcare Innovations Fund LP
Deerfield Mgmt IV LP
Nuvalent Inc
Deerfield Mgmt V LP
Deerfield Private Design Fund V LP
Bicara Therapeutics Inc
AdaptHealth Corp
DA32 Life Science Tech Acquisition Corp
Oncorus Inc
Frazier Lifesciences Acquisition Corp
Acutus Medical Inc
PepGen Inc
DFP Healthcare Acquisitions Corp
Xilio Therapeutics Inc
CareMax Inc
Singular Genomics Systems Inc
Werewolf Therapeutics Inc
Terns Pharmaceuticals Inc
Peak Bio Inc
Graybug Vision Inc
Annexon Inc
Nkarta Inc
Generation Bio Co
Revolution Medicines Inc
Schrodinger Inc
Black Diamond Therapeutics Inc
Q32 Bio Inc
Cabaletta Bio Inc
Deerfield Special Situations Fund LP
Korro Bio Inc
Aclaris Therapeutics Inc
Aerie Pharmaceuticals Inc
Kiniksa Pharmaceuticals International PLC
Keenova Therapeutics PLC
GYRE Therapeutics Inc
Deerfield International Master Fund LP
Proteon Therapeutics Inc
Societal CDMO Inc
eHealth Inc
Vanda Pharmaceuticals Inc
Xenoport Inc
AveXis Inc
Antares Pharma Inc
RegenxBio Inc
Deerfield Private Design International II LP
Auspex Pharmaceuticals Inc
Deerfield Private Design Fund II LP
Auxilium Pharmaceuticals Inc
Deerfield Special Situations International Master Fund LP
Loxo Oncology Inc
Adverum Biotechnologies Inc
NxStage Medical Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 1,084,012 $5.00 5,420,060
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 2,000,000 $5.00 10,000,000
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 1,084,010 $5.00 5,420,050
Zafgen Inc LRMR
Common Stock
2026-02-27 Buy 831,978 $5.00 4,159,890
Nuvalent Inc NUVL
Class A Common Stock
2025-11-24 Sell 371,287 $95.45 35,439,344
Nuvalent Inc NUVL
Class A Common Stock
2025-11-24 Sell 371,287 $95.45 35,439,344
Zafgen Inc LRMR
Common Stock
2025-07-31 Buy 3,387,539 $3.20 10,840,125
Zafgen Inc LRMR
Common Stock
2025-07-31 Buy 3,387,529 $3.20 10,840,093
Zafgen Inc LRMR
Common Stock
2025-07-31 Buy 2,599,932 $3.20 8,319,782
Nuvalent Inc NUVL
Class A Common Stock
2024-10-22 Sell 1,000,000 $97.75 97,750,000
Nuvalent Inc NUVL
Class A Common Stock
2024-10-22 Sell 1,000,000 $97.75 97,750,000
Bicara Therapeutics Inc BCAX
Common Stock
2024-09-17 Buy 35,000 $18.00 630,000
Bicara Therapeutics Inc BCAX
Common Stock
2024-09-17 Conversion 862,587
Bicara Therapeutics Inc BCAX
Common Stock
2024-09-17 Conversion 862,587
Bicara Therapeutics Inc BCAX
Common Stock
2024-09-17 Buy 35,000 $18.00 630,000
Bicara Therapeutics Inc BCAX
Series C Preferred Stock · derivative
2024-09-17 Conversion 7,973,325
Bicara Therapeutics Inc BCAX
Series C Preferred Stock · derivative
2024-09-17 Conversion 7,973,325
AdaptHealth Corp AHCO
Class A Common Stock
2024-03-12 Sell 114,906 $10.70 1,229,494
AdaptHealth Corp AHCO
Class A Common Stock
2024-03-11 Sell 94,567 $10.92 1,032,672
AdaptHealth Corp AHCO
Class A Common Stock
2024-03-11 Sell 88,040 $11.13 979,885
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com